Evidence map›Paper›PMID 34615372›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2021

Myeloid Mineralocorticoid Receptor Transcriptionally Regulates P-Selectin Glycoprotein Ligand-1 and Promotes Monocyte Trafficking and Atherosclerosis.

Joshua J Man, Qing Lu, M Elizabeth Moss, Brigett Carvajal, Wendy Baur, Amanda E Garza, Roy Freeman, Marina Anastasiou, Njabulo Ngwenyama, Gail K Adler and 2 more

Open access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Impact of aldosterone deficiency on the development of diuretic resistance in mice.Pflugers Archiv : European journal of physiology · 2025
    Article
  6. The mineralocorticoid receptor in diabetic kidney disease.American journal of physiology. Renal physiology · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Aging of the Arterial System.International journal of molecular sciences · 2023
    Review
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Joshua J ManMolecular Cardiology Research Institute (J.J.M., Q.L., M.E.M., B.C., W.B., I.Z.J.), Tufts University School of Medicine, Boston, MA.ORCID 0000-0002-2562-5715
Qing LuMolecular Cardiology Research Institute (J.J.M., Q.L., M.E.M., B.C., W.B., I.Z.J.), Tufts University School of Medicine, Boston, MA.
M Elizabeth MossMolecular Cardiology Research Institute (J.J.M., Q.L., M.E.M., B.C., W.B., I.Z.J.), Tufts University School of Medicine, Boston, MA.ORCID 0000-0002-9761-7263
Brigett CarvajalMolecular Cardiology Research Institute (J.J.M., Q.L., M.E.M., B.C., W.B., I.Z.J.), Tufts University School of Medicine, Boston, MA.
Wendy BaurMolecular Cardiology Research Institute (J.J.M., Q.L., M.E.M., B.C., W.B., I.Z.J.), Tufts University School of Medicine, Boston, MA.
Amanda E GarzaDivision of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital (A.E.G., G.K.A.), Harvard Medical School, Boston, MA.
Roy FreemanDepartment of Neurology, Beth Israel Deaconess Medical Center (R.F.), Harvard Medical School, Boston, MA.ORCID 0000-0003-3976-6022
Marina AnastasiouDepartment of Immunology (M.A., N.N., P.A.), Tufts University School of Medicine, Boston, MA.
Njabulo NgwenyamaDepartment of Immunology (M.A., N.N., P.A.), Tufts University School of Medicine, Boston, MA.
Gail K AdlerDivision of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital (A.E.G., G.K.A.), Harvard Medical School, Boston, MA.
Pilar AlcaideDepartment of Immunology (M.A., N.N., P.A.), Tufts University School of Medicine, Boston, MA.ORCID 0000-0003-3013-3982
Iris Z JaffeMolecular Cardiology Research Institute (J.J.M., Q.L., M.E.M., B.C., W.B., I.Z.J.), Tufts University School of Medicine, Boston, MA.ORCID 0000-0001-9300-1253
Tufts University · USBrigham and Women's Hospital · USBeth Israel Deaconess Medical Center · US

Funding

The Role of Vascular MR-Regulated Genes in Vascular Function and DiseaseR01HL095590 · NHLBI · TUFTS MEDICAL CENTER · PI Iris Z Jaffe · 2009 to 2026
$7.7M
Tufts Post-Baccalaureate Research Education ProgramR25GM066567 · NIGMS · TUFTS UNIVERSITY BOSTON · PI RIOS, MARIBEL · 2002 to 2024
$5.7M
Mechanisms of T cell activation in cardiac fibrosis and non-ischemic heart failureR01HL144477 · NHLBI · TUFTS UNIVERSITY BOSTON · PI ALCAIDE ALONSO, MARIA PILAR · 2019 to 2023
$3.2M
T Cell Mediated Immune Responses as a Regulator of Heart FailureR01HL123658 · NHLBI · TUFTS UNIVERSITY BOSTON · PI ALCAIDE ALONSO, MARIA PILAR · 2014 to 2018
$2.2M
Aldosterone and Diabetic Cardiovascular Disease: Research and Mentoring ProgamK24HL103845 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ADLER, GAIL KURR · 2011 to 2021
$1.6M
The Role of Endothelial Cell Mineralocorticoid Receptors in the Development of Vascular Inflammation and AtherosclerosisF30HL137255 · NHLBI · TUFTS UNIVERSITY BOSTON · PI MOSS, MARY ELIZABETH · 2017 to 2021
$184k
Role of the myeloid mineralocorticoid receptor in vascular inflammation in atherosclerosisF30HL152505 · NHLBI · TUFTS UNIVERSITY BOSTON · PI MAN, JOSHUA JAMES · 2020 to 2022
$144k
Deciphering the mechanisms of CD4 T cell activation in nonischemic heart failureF31HL140883 · NHLBI · TUFTS UNIVERSITY BOSTON · PI NGWENYAMA, NJABULO · 2018 to 2019
$70k
NHLBI NIH HHS F30 HL137255NHLBI NIH HHS F30 HL152505NHLBI NIH HHS F31 HL140883NHLBI NIH HHS K24 HL103845NHLBI NIH HHS R01 HL095590NHLBI NIH HHS R01 HL123658NHLBI NIH HHS R01 HL144477NIGMS NIH HHS R25 GM066567
6 · The paper itself

Abstract

Objective: MR (mineralocorticoid receptor) activation associates with increased risk of cardiovascular ischemia while MR inhibition reduces cardiovascular-related mortality and plaque inflammation in mouse atherosclerosis. MR in myeloid cells (My-MR) promotes inflammatory cell infiltration into injured tissues and atherosclerotic plaque inflammation by unclear mechanisms. Here, we examined the role of My-MR in leukocyte trafficking and the impact of sex. Approach and Results: We confirm in vivo that My-MR deletion (My-MR-KO) in ApoE-KO mice decreased plaque size. Flow cytometry revealed fewer plaque macrophages with My-MR-KO. By intravital microscopy, My-MR-KO significantly attenuated monocyte slow-rolling and adhesion to mesenteric vessels and decreased peritoneal infiltration of myeloid cells in response to inflammatory stimuli in male but not female mice. My-MR-KO mice had significantly less PSGL1 (P-selectin glycoprotein ligand 1) mRNA in peritoneal macrophages and surface PSGL1 protein on circulating monocytes in males. In vitro, MR activation with aldosterone significantly increased PSGL1 mRNA only in monocytes from MR-intact males. Similarly, aldosterone induced, and MR antagonist spironolactone inhibited, PSGL1 expression in human U937 monocytes. Mechanistically, aldosterone stimulated MR binding to a predicted MR response element in intron-1 of the PSGL1 gene by ChIP-qPCR. Reporter assays demonstrated that this PSGL1 MR response element is necessary and sufficient for aldosterone-activated, MR-dependent transcriptional activity. Conclusions: These data identify PSGL1 as a My-MR target gene that drives leukocyte trafficking to enhance atherosclerotic plaque inflammation. These novel and sexually dimorphic findings provide insight into increased ischemia risk with MR activation, cardiovascular protection in women, and the role of MR in atherosclerosis and tissue inflammation.

Indexed as

Cell AdhesionLeukocyte RollingAdultAnimalsAorta, ThoracicAortic DiseasesAtherosclerosisDisease Models, AnimalFemaleHEK293 CellsHumansHypoglycemiaMacrophages, PeritonealMaleMembrane GlycoproteinsMiceMembrane GlycoproteinsMineralocorticoid Receptor AntagonistsNR3C2 protein, humanNr3c2 protein, mouseP-selectin ligand proteinReceptors, MineralocorticoidSpironolactoneatherosclerosisinflammationmineralocorticoid receptorsmonocytesmyeloid cellsselectins

Identifiers

PMID34615372
PMCPMC8601161
OpenAlexW3202150567

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.